Successful treatment of metastatic hormone-refractory prostate cancer with malignant pericardial tamponade using docetaxel

Urology

Volumn 59, Issue 1, 2002, Pages 137-

  Hayes Lattin, Brandon M ^a   Kovach, Peter A ^b   Henner, W David ^a   Beer, Tomasz M ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Willamette Valley Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BICALUTAMIDE; CISPLATIN; DIETHYLSTILBESTROL; DOCETAXEL; LEUPRORELIN; METHYLPREDNISOLONE;

ADULT; ARTICLE; AUTOPSY; CASE REPORT; HEART TAMPONADE; HUMAN; MALE; METASTASIS; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PLEURA EFFUSION; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA;

EID: 0036141235     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0090-4295(01)01481-9     Document Type: Article

References (12)

1. Metastases from cancer of the prostate
2. Cardiac lymphatic involvement by metastatic tumor
3. Adenocarcinoma of prostate and malignant pericardial effusion
4. Prostatic carcinoma presenting as pericardial tamponade
5. Carcinoma of the prostate metastatic to the heart; report of a case
6. Massive pericardial effusion due to metastatic prostatic carcinoma; a case report
7. Metastatic neoplasms of the heart
8. Recurrent cardiac tamponade in cancer of the prostate
9. Pleuro-pericardial metastases of prostatic adenocarcinoma
10. Pericardial effusion in patients with cancer; outcome with contemporary management strategies
11. Malignancy-related pericardial effusion; 127 cases from the Roswell Park Cancer Institute
12. Hormone-refractory prostate cancer; an evolving standard of care